Patients with CRC have an imbalanced gut microbiome or dysbiosis, reflecting a decrease in beneficial bacteria and an increase in pathobionts, such as polyketide synthase positive (pks+) Escherichia coli (Wirbel et al., 2019). This evidence concerns the gene ARAF and colorectal carcinoma.